Journal of Oral Health and Community Dentistry

Register      Login

VOLUME 7 , ISSUE 3 ( September-December, 2013 ) > List of Articles


Interleukin-1 as a Marker of Periodontitis with Oral Carcinoma – A Biochemical Study

U Sudhakar, JA Sivaranjani, MC Dayan

Citation Information : Sudhakar U, Sivaranjani J, Dayan M. Interleukin-1 as a Marker of Periodontitis with Oral Carcinoma – A Biochemical Study. J Oral Health Comm Dent 2013; 7 (3):137-139.

DOI: 10.5005/johcd-7-3-137

License: CC BY-NC 3.0

Published Online: 01-03-2015

Copyright Statement:  Copyright © 2013; The Author(s).



This biochemical study aimed at evaluating the level of interleukin-1beta in patients with oral squamous cell carcinoma as a reflection of amount of bone destruction leading to periodontitis in comparison with the normal healthy individuals.


The subjects were grouped under four major categories like chronic periodontits, chronic periodontitis with oral squamous cell carcinoma and squamous cell carcinoma alone and the control. Each group consisted of 10 subjects each. Unstimulated whole saliva was collected from each subject. IL-1 in saliva was measured by enzyme linked immunosorbent assay.


In the present study, IL-1 was significantly more in patients with cancer and periodontitis than patients with only cancer. When compared with the normal subjects IL-1 value was significantly more in subjects with carcinoma (0.016).


This study presents the first evidence of association between level of salivary biomarker interleukin 1 in subjects with periodontitis and in oral squamous cell carcinoma.

PDF Share
  1. Oral cavity and pharynx cancer incidence rates in united states 1975-1998. Oral oncology 2002;38:610–17.
  2. Innate immunity gone away:linking microbial infection to chronic inflammation and cancer. Cell 2006;124:823–35.
  3. Chronic periodontitis and the head and neck squamous cell carcinoma. Cancer Epidemiology Biomarkers Prevention 2009;18(9): 2406–12.
  4. Potential for gingival crevice fluid measures as predictors of risk of periodontal disease. Periodontal 2000, 2003;31:167–80.
  5. Periodontal diseases as a specific, albeit chronic infection :diagnosis and treatment. Clinical Microbiology Rev 2001;14:727–52.
  6. Cytokine profiles of extracted from humans with periodontal diseases. J Dental Research 1998;77(1):16–26.
  7. Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 1998;77(1):16–26.
  8. Marginal periodontium as a potential reservoir of human papilloma virus in oral mucosa. J Periodontal 2005;76(3):358–63.
  9. Periodontitis lesions are source of cytomegalovirus and Epstein Barr Virus. J Periodontal Res 2005;40:187–91.
  10. Is Periodontitis associated with oral neoplasms? J Periodontology 2005; 76:406–10.
  11. Leukocyte-endothelial adhesion molecules. Blood 1994;84(7):2068–01.
  12. An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist. The New England Journal of Medicine 2009;360:2426–37.
  13. Sullaivan Mary E et al. Chronic periodontitis and risk of tongue cancer. Arch Otolaryngol Head Neck Surg 2007;133:450–54.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.